BACKGROUND: Nicotine is one of the world's most addictive substances and the primary reason that humans inhale tobacco smoke. The pharmacological effects of nicotine can be investigated in planarians, aquatic flatworms that possess an integrated neural network including cephalic ganglia that some consider the earliest 'brain' and spinal cord. Here, we tested the hypothesis that nicotine exposure elicits mammalian-like behaviors in planarians. METHODS: Planarian motility and stereotypy (C-shape hyperkinesias) were quantified following acute nicotine exposure. During repeated nicotine exposure, we investigated the presence of withdrawal, tolerance, behavioral sensitization, and environmental place conditioning. RESULTS: Acute nicotine exposure increased stereotypical activity and elicited biphasic effects on motility. A low concentration (0.01 mM) increased motility whereas higher concentrations (0.3-10mM) elicited the opposite effect. Planarians exposed to nicotine (0.03 mM) for 60 min and then tested in water displayed reduced motility that was not observed during exposure to water, acute nicotine, or continuous nicotine. Nicotine-treated planarians withdrawn from the drug for 3 days before being challenged with nicotine displayed behavioral sensitization at low concentrations (0.1, 0.3mM) but tolerance at higher concentrations (1, 3mM). Planarians conditioned with nicotine in the ambient light (non-preferred environment) displayed a reduction in their natural preference for a dark environment. CONCLUSIONS: The present results suggest nicotine elicits mammalian-like effects in planarians, including decreased motility and increased stereotypy following acute administration and abstinence-induced withdrawal, behavioral sensitization, tolerance, and place conditioning during repeated exposure.
BACKGROUND:Nicotine is one of the world's most addictive substances and the primary reason that humans inhale tobacco smoke. The pharmacological effects of nicotine can be investigated in planarians, aquatic flatworms that possess an integrated neural network including cephalic ganglia that some consider the earliest 'brain' and spinal cord. Here, we tested the hypothesis that nicotine exposure elicits mammalian-like behaviors in planarians. METHODS: Planarian motility and stereotypy (C-shape hyperkinesias) were quantified following acute nicotine exposure. During repeated nicotine exposure, we investigated the presence of withdrawal, tolerance, behavioral sensitization, and environmental place conditioning. RESULTS: Acute nicotine exposure increased stereotypical activity and elicited biphasic effects on motility. A low concentration (0.01 mM) increased motility whereas higher concentrations (0.3-10mM) elicited the opposite effect. Planarians exposed to nicotine (0.03 mM) for 60 min and then tested in water displayed reduced motility that was not observed during exposure to water, acute nicotine, or continuous nicotine. Nicotine-treated planarians withdrawn from the drug for 3 days before being challenged with nicotine displayed behavioral sensitization at low concentrations (0.1, 0.3mM) but tolerance at higher concentrations (1, 3mM). Planarians conditioned with nicotine in the ambient light (non-preferred environment) displayed a reduction in their natural preference for a dark environment. CONCLUSIONS: The present results suggest nicotine elicits mammalian-like effects in planarians, including decreased motility and increased stereotypy following acute administration and abstinence-induced withdrawal, behavioral sensitization, tolerance, and place conditioning during repeated exposure.
Authors: S M Rawls; F Karaca; I Madhani; V Bhojani; R L Martinez; M Abou-Gharbia; R B Raffa Journal: Neuroscience Date: 2010-06-23 Impact factor: 3.590
Authors: L Ramoz; S Lodi; P Bhatt; A B Reitz; C Tallarida; R J Tallarida; R B Raffa; S M Rawls Journal: Neuroscience Date: 2012-01-20 Impact factor: 3.590
Authors: Emily Dziedowiec; Sunil U Nayak; Keenan S Gruver; Tyra Jennings; Christopher S Tallarida; Scott M Rawls Journal: Neuroscience Date: 2018-06-27 Impact factor: 3.590
Authors: Christopher S Tallarida; Erin Egan; Gissel D Alejo; Robert Raffa; Ronald J Tallarida; Scott M Rawls Journal: Neuropharmacology Date: 2014-01-15 Impact factor: 5.250
Authors: Kevin Ouyang; Sunil Nayak; Young Lee; Erin Kim; Michael Wu; Christopher S Tallarida; Scott M Rawls Journal: Neurosci Lett Date: 2016-11-11 Impact factor: 3.046
Authors: Alexandre Vouga; Ryan A Gregg; Maryah Haidery; Anita Ramnath; Hassan K Al-Hassani; Christopher S Tallarida; David Grizzanti; Robert B Raffa; Garry R Smith; Allen B Reitz; Scott M Rawls Journal: Neuropharmacology Date: 2014-12-09 Impact factor: 5.250
Authors: Daniel J Bach; Matthew Tenaglia; Debra L Baker; Sean Deats; Erica Montgomery; Oné R Pagán Journal: Neurosci Lett Date: 2016-09-08 Impact factor: 3.046